A recent trial performed in China comparing TruScreen ® with Liquid Based Cytology and primary HPV testing demonstrated TruSreen® to have higher sensitivity than Liquid Based Cytology for the detection of high-grade cervical precancer and cancer, and confirmed the value of TruScreen® for population screening in China.
The test results themselves are great but I think the phrase "population screening" refers to a possible state sponsored national screening program. Which is quite outside the current distribution arrangements. I am reading between the lines but I know this has been a possibility for quite some time. If it comes off we are all on easy street.
Cheers from a happy holder.
PLT Price at posting:
0.0¢ Sentiment: ST Buy Disclosure: Held
